Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
98 Cards in this Set
- Front
- Back
2nd process of pharmacodynamics
|
Distribution
|
|
The distribution of a drug throughout the body depends on three factors:
|
1. the drug’s ability to leave the blood
2. blood flow to the tissues 3. the drug’s ability to enter cells. |
|
There are two conditions that low blood flow can affect the outcome of the drug action:
|
Abscess
Tumor |
|
Protein-Binding affects the ____ of a drug. When_____ to protein, it is unable to pass though the capillary walls.
The bonds will dissolve in time, and the drug molecules will become free and ______. |
distribution
bound active |
|
Do highly protein bound drugs have longer or shorter durations of action?
|
Longer duration
|
|
Protein-binding- drugs circulate in the plasma either ___ or ____ to plasma proteins (usually _____)
|
bound
unbound albumin |
|
Albumin is a ____ molecule and because of this, albumin always remains in the blood stream.
|
large
|
|
The degree to which Protein-binding- drugs are bound is determined by the ____ between albumin and the drug. It is represented by ____.
|
attraction
percentages |
|
How does the Blood-Brain Barrier work?
|
It is a highly selective protective mechanism.
The cells of the CNS system have very tight capillary walls that limit movements of drug molecules into drug tissues. |
|
Metabolism of drugs occurs primarily in the ____.
|
liver
|
|
A product of metabolism is called a _______.
|
metabolite
|
|
HEPATIC FIRST-PASS EFFECT
|
initial biotransformation of a drug that produces altered (usually less) pharmacologically active molecules. As drugs are metabolized through the liver the loss of effectiveness is called the first-pass effect.
|
|
Drugs that experience a high first-pass effect may need _____ oral doses to achieve a therapeutic level of circulating drug.
|
higher
|
|
A drug given via the ___ route may be extensively metabolized or broken down by the liver before reaching the systemic circulation (high first-pass effect).
|
oral
|
|
First pass _______ may significantly limit the drugs effect.
|
metabolism
|
|
Drugs given ____ bypass the liver, preventing the first-pass effect from taking place, and more drug reaches the circulation.
|
IV
|
|
Example of a drug with a high first pass metabolism?
|
Nitroglycerin
|
|
What are the routes that bypass the liver (dodge the first pass effect)?
|
Everything besides PO!!
|
|
Liver metabolism is predominantly achieved by specific ___ ____.
|
liver enzymes
|
|
The microsomal enzymes in the liver that are responsible for liver metabolism are called the ______ ____ ________.
|
cytochrome P-450 system
|
|
The enzyme ______ is the most common and is responsible for the metabolism of most drugs.
|
CYP3A4
|
|
Some drugs either induce or inhibit the P-450 system, altering _______ of other drugs.
|
metabolism
|
|
When a large quantity of one of the P-450 system enzymes is present, more _____ can occur through this pathway.
|
metabolism
|
|
An increase in metabolism rapidly ________ the amount of circulating drug.
|
decreases
|
|
Drugs that induce a hepatic enzyme will cause ____ metabolism to occur, which will rapidly _____ the amount of active circulating drug.
|
more
decrease |
|
Drugs that inhibit a hepatic enzyme will cause ____ metabolism to occur, which will rapidly _____ the amount of active circulating drug.
|
less
increase |
|
What is one common drug that potentially INHIBITS the p450 enzymes?
|
grapefruit juice
|
|
What is one common drug that potentially INCREASES the activity of P450 enzymes?
|
tobacco
|
|
_______ is the process of removing a drug, or its metabolites, from the body.
|
Excretion
|
|
The most common route for drug excretion is through the ______.
|
urine
|
|
Diseases and pathophysiologic changes in the kidney decrease the effectiveness of the kidney in drug ____.
|
excretion
|
|
3 processes are involved in renal excretion of drugs.
|
1. glomerular filtration.
2. passive tubular reabsorption. 3. active tubular secretion. |
|
glomerular filtration
|
Most drug particles pass easily through the spaces of the capillary walls into the urine in the proximal tubule.
|
|
passive tubular reabsorption
|
The drug particles will try to move from the area of greater concentration to that of lesser concentration.
|
|
active tubular secretion
|
Active transport systems in the renal tubule work to move some drugs from the blood and into the urine.
|
|
Drug excretion can be increased if the ____ of the urine encourages the drug to become an ion.
|
pH
|
|
Overuse of the active transport system also affects _____.
|
excretion
|
|
2 drugs can be given together to deliberately slow the rate of _______ of one or both of the drugs.
|
excretion
|
|
The ____-____ if the combined process of both metabolism and excretion
|
Half-Life
|
|
Half-Life
|
The time it takes for ½ the drug concentration to be eliminated from the body
|
|
In one half-life, a set _____ of the drug molecules present in the blood will be eliminated, not an absolute set number of drug molecules.
|
percentage
|
|
Steady State
|
The point at which the amount of drug being administered and the amount being eliminated are equal
|
|
At ____ to _____ half-lives, steady state is achieved.
|
four to five
|
|
The full ____________ response of a particular drug dose is measured when the drug has achieved steady state.
|
pharmacotherapeutic
|
|
Steady state will never equal ____
|
100%
|
|
Onset
|
time it takes to reach minimum effective concentration
|
|
Peak
|
time it takes to reach highest blood or plasma concentration
|
|
Duration
|
length of time the drug has a pharmacologic effect
|
|
This rate is called “clearance” or “clearance rate of the drug”
|
Rate at which drug molecules disappear from the circulatory system
|
|
Renal excretion and hepatic metabolism are the major modes of _______.
|
clearance
|
|
____________ is the biologic, chemical, and physiologic actions of a particular drug within the body.
|
Pharmacodynamics
|
|
Drugs cannot create new responses in the body; they can only ___ __, ___ ___, ______, or _____ a response that the body is inherently capable of producing.
|
turn on, turn off, promote, or block
|
|
At the ____ ____, the drug is able to stimulate the cell to act in a way that the cell is designed to act.
|
receptor site
|
|
Each type of receptor is responsible for producing a particular effect in the cell.
An ______ causes the cell to act. An _______ or blocker prevents something else from attaching to the cell blocking and action. |
AGONIST
ANTAGONIST |
|
Single-occupancy theory
|
The intensity of the body’s response to the drug is directly related to the number of receptors occupied by the drug.
The maximum response occurs when all of the receptors have drug molecules attached. |
|
Modified occupancy theory
|
Different drugs have different strengths of attractions, or affinity, for receptor sites.
Once a drug is attached to a receptor, it has different abilities to stimulate the receptor. |
|
Receptors are not static.
Continual stimulation from an agonist usually makes the drug ___ _____. |
less effective.
|
|
Continual blockage from an antagonist usually makes the drug ___ likely to react.
|
more
|
|
Drugs exert their effect by reacting _____ or _______ with other molecules in the body.
|
physically
chemically |
|
Potency and Efficacy
|
The level of the drug needed in the body to produce an effect
|
|
Maintenance dose
|
daily dose
|
|
Loading dose
|
larger than usual dose to reach an therapeutic effect quicker
|
|
Therapeutic index
|
The difference between an effective dose and a toxic dose
|
|
minimum effective concentration
|
Certain level of drug must be present in the body to have any effect
|
|
The amount of a drug that must be given in order to produce a particular response is called the ______ of a drug.
|
potency
|
|
How well a drug produces its desired effect is called ______.
|
efficacy
|
|
The dose that is given consistently over time is called the _____ _______.
|
maintenance dose
|
|
Patients who are started on drug therapy using the standard maintenance dose arrive at steady state after ______ half-lives.
|
4-5
|
|
The loading dose is computed so that after some of the drug is eliminated, the drug concentration in the body is still in the ______ range.
|
therapeutic
|
|
The point at which the dose would be fatal in 50% of the population receiving that dose is called lethal dose 50% (_____).
|
LD50
|
|
The relation of ED50 to LD50 is called the ____ ______.
|
therapeutic index
|
|
As drug levels within the body increase, the patient is more likely to experience____ _____ from drug therapy.
|
adverse effects
|
|
To help determine whether a drug’s dose is sufficient to be in the therapeutic range, but not so high as to cause adverse effects, ____ ____ of the drug are often measured.
|
blood levels
|
|
The therapeutic range can only be considered an _______.
|
average
|
|
All drugs have some type of adverse effect(s). True or False?
|
True
|
|
An ____ _____ of drug therapy is usually an undesirable effect other than the intended therapeutic effect.
|
adverse effect
|
|
A ___ _____ occurs when two drugs or a drug and another element have an effect on each other.
|
drug interaction
|
|
An allergic response is a(an) ____ _____ response.
|
immune system
|
|
After an allergic response to a drug, the ____-_____ response happens when the drug is taken again.
|
antigen–antibody
|
|
After an allergic response, ymptoms may become more _____ each time the drug is introduced into the body.
|
severe
|
|
The most serious allergic response is called_________.
|
anaphylaxis
|
|
_________ responses are unusual and in fact may be the opposite of what is anticipated.
|
Idiosyncratic
|
|
Which of the following is not a symptom of anaphylaxis?
A. Bronchospasms B. Vasodilation C. Convulsions D. Urticaria |
D. Urticaria
|
|
Neurotoxicity
|
Signs and symptoms: drowsiness, auditory and visual disturbances, and seizures.
|
|
Hepatotoxicity
|
If liver damage occurs, the drug will not be metabolized as efficiently.
|
|
Nephrotoxicity
|
Signs and symptoms: decreased urinary output, elevated blood urea nitrogen, increased serum creatinine, altered acid-base balance, and electrolyte imbalances.
|
|
Ototoxicity
|
Signs and symptoms: tinnitus, hearing loss, light-headedness, vertigo, and nausea.
|
|
Cardiotoxicity
|
Signs and symptoms: irregularities in conduction, heart failure, and damage to the myocardium.
|
|
Immunotoxicity
|
Signs and symptoms: immunosuppression.
|
|
Additive Effect
|
An effect in which two substances or actions used in combination produce a total effect the same as the sum of the individual effects. (1+1=2)
|
|
Synergistic Effect
|
occurs when 2 or more "unlike" drugs are used together to produce a combined effect, and the outcome is a drug effect greater than either drug's activity alone (1+1=3)
|
|
Potentiated Effect
|
an interaction in which the effect of only one of the to drugs is increased. (1/2+1=2)
|
|
Antagonistic Effect
|
the opposite of synergistic effect. Results in an effect that is less than the effect of either drug alone because the 2nd drug either diminishes or cancels the effect of the 1st drug. (1+1=0)
|
|
5 key categories to look at when assessing Core Pt. Variables
|
health status
lifespan and gender lifestyle, diet, and habits environment culture and inherited traits |
|
bioavailability
|
term used to describe the fraction of the administered dose that reaches the systemic circulation and produces effects
|
|
IV drugs have ___% bioavailability
|
100%
|
|
Bioequivalent
|
2 drugs that ahve the same bioavailability (both drugs absorbed into circulation system in identical amounts and with same absorption rates)
|
|
How do you maximize therapeutic effects and minimize adverse effects?
|
Check pts history, constant evaluation, admin drugs correctly, etc.
|